Last month, Johnson & Johnson recalled one lot of the antipsychotic drug Risperdal Consta and 200,000 bottles of liquid Motrin for infants.
The recall was done because the medications were found to have mold (in the case of Risperdal) and small plastic particles (in the case of Motrin), according to the New York Times.
Unfortunately, this is not the first recall from Johnson & Johnson in recent years. In fact, the company has been plagued with quality control problems for the past several years. In 2010, a Congressional hearing was called to look into Johnson & Johnson. During the hearing, members of the House Committee on Oversight and Government Reform expressed concern that the company was “deceptive, dishonest, and willing to put the health of children at risk.”
Today, these latest recalls are renewing concerns about the pharmaceutical giant’s quality control issues.
Because of Johnson & Johnson’s past recalls of everything from Tylenol to contact lenses and artificial hips, it is operating under a “consent decree” with the Food and Drug Administration. This means, reports the New York Times, “it has promised to overhaul production at three manufacturing plants.”
It could be that Johnson & Johnson is issuing these recalls out of caution, not wanting to wait until complaints come rolling in and the public loses faith in the company. However, others suggest that the continued recalls are evidence that Johnson & Johnson hasn’t fully fixed the problems that it has had.
As an Alabama personal injury attorney, it is very unsettling to learn about companies with a repeated history of quality control problems. Fortunately, no one seems to have been harmed by the faulty drugs that Johnson & Johnson has distributed.
I encourage you to check for recalls of the products you own often. You can see a list of recalls on the Consumer Product Safety Commission website, or you can find a list of major recent recalls on our Recalls page.